Showing results (391-400 of 938) with videos related to

Sort By:
Pageof 94
Biochemical Pharmacology|October 1, 1988
Ex vivo inhibition of rat brain cytochrome P-450 activity by stiripentolM Mesnil, B Testa, P Jenner
Brain & Development|May 1, 1992
Early monoaminergic dysfunctionY Takeuchi, T Sawada, P Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year periodN Quinn, D Parkes, I Janota, et al.
Neurologia (Barcelona, Spain)|July 1, 1989
[Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm]F Grandas, J Elston, N Quinn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Paroxysmal dystonic head tremorA J Hughes, A J Lees, C D Marsden
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization studyA E Kingsbury, C D Marsden, O J Foster
Yonsei Medical Journal|May 19, 2000
The pedunculopontine nucleus: its role in the genesis of movement disordersM S Lee, J O Rinne, C D Marsden
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Pathological report of four patients presenting with cranial dystoniasW R Gibb, A J Lees, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1984
On the significance of giant somatosensory evoked potentials in cortical myoclonusJ C Rothwell, J A Obeso, C D Marsden
Pageof 94